Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …

Respiratory syncytial virus (RSV) is amongst the most important pathogenic infections of
childhood and is associated with significant morbidity and mortality. Although there have …

Guidance from the American Academy of Pediatrics (AAP) for the use of palivizumab
prophylaxis against respiratory syncytial virus (RSV) was first published in a policy statement …

BACKGROUND: Respiratory syncytial virus (RSV) infection is a leading cause of
hospitalization among infants. However, estimates of the RSV hospitalization burden have …

Evidenced-based guidelines for management of infants and children with community-
acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and …

Guidance from the American Academy of Pediatrics (AAP) for the use of palivizumab
prophylaxis against respiratory syncytial virus (RSV) was first published in a policy statement …

Respiratory viral infections are associated with a wide range of acute syndromes and
infectious disease processes in children and adults worldwide. Many viruses are implicated …

Background Respiratory syncytial virus (RSV) is a common cause of infant hospitalizations
and is increasingly recognized as a cause of considerable morbidity and mortality. No …

INTRODUCTION Even with intimate exposure to a virus, some people fail to become
infected. Variable transmission partly depends on the dose and duration of exposure but is …

Late preterm (LP) infants are defined as those born at 34-0/7 to 36-6/7 weeks' gestational
age. LP infants were previously referred to as near term infants. The change in terminology …